Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Similar articles for PubMed (Select 7954266)

1.

Excessive spinal cord toxicity from intensive central nervous system-directed therapies.

Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, Moertel CL, Priest JR.

Cancer. 1994 Dec 1;74(11):3034-41. Review.

PMID:
7954266
2.

Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.

Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR.

J Natl Cancer Inst. 1992 Feb 19;84(4):252-6.

PMID:
1734087
3.

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.

Reiter A, Schrappe M, Ludwig WD, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, Müller-Weihrich S, Ritter J, et al.

Blood. 1992 Nov 15;80(10):2471-8.

4.

Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.

Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.

Klin Padiatr. 1998 Jul-Aug;210(4):192-9.

PMID:
9743952
5.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.

Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J; Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.

J Clin Oncol. 2001 Apr 1;19(7):1935-42.

PMID:
11283125
6.

Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.

Reiter A.

Baillieres Clin Haematol. 1994 Jun;7(2):321-37. Review.

PMID:
7803904
7.

The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.

Morra E, Lazzarino M, Brusamolino E, Pagnucco G, Castagnola C, Bernasconi P, Orlandi E, Corso A, Santagostino A, Bernasconi C.

Cancer. 1993 Jul 15;72(2):439-45.

PMID:
8319175
9.

Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

Morra E, Lazzarino M, Inverardi D, Brusamolino E, Orlandi E, Canevari A, Pagnucco G, Bernasconi C.

J Clin Oncol. 1986 Aug;4(8):1207-11.

PMID:
3461134
10.

Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.

Bleyer A, Choi M, Wang SJ, Fuller CD, Raney RB.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1205-10. doi: 10.1002/pbc.22164.

PMID:
19821538
11.

Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.

Moser AM, Adamson PC, Gillespie AJ, Poplack DG, Balis FM.

Cancer. 1999 Jan 15;85(2):511-6.

PMID:
10023723
12.

CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.

Nathan PC, Maze R, Spiegler B, Greenberg ML, Weitzman S, Hitzler JK.

Pediatr Blood Cancer. 2004 Jan;42(1):24-9.

PMID:
14752790
13.

Intrathecal chemotherapy with antineoplastic agents in children.

Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P, Riccardi R.

Paediatr Drugs. 2001;3(4):237-46. Review.

PMID:
11354696
15.

Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.

Spreafico F, Massimino M, Luksch R, Casanova M, Cefalo GS, Collini P, Ferrari A, Polastri D, Terenziani M, Gasparini M, Fossati-Bellani F.

J Clin Oncol. 2002 Jun 15;20(12):2783-8.

PMID:
12065554
16.
17.
18.

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.

Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P.

Cancer. 1996 Apr 1;77(7):1315-23.

PMID:
8608509
19.

Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.

Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.

Strahlenther Onkol. 2003 Sep;179(9):626-32.

PMID:
14628129
20.

Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).

Morra E, Lazzarino M, Alessandrino EP, Inverardi D, Regazzi Bonora M, Pagnucco G, Orlandi E, Bernasconi P, Canevari A, Rondanelli R, et al.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:101-3.

PMID:
2713552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk